Financial aspects of sentinel lymph node biopsy in early breast cancer

S. Severi, E. Gazzoni, A. Pellegrini, M. Sansovini, G. Raulli, C. Corbelli, M. Altini, G. Paganelli

Research output: Contribution to journalArticle

Abstract

Aim. At present, early breast cancer is treated with conservative surgery of the primary lesion (BCS) along with axillary staging by sentinel lymph node biopsy (SLNB). Although the scintigraphic method is standardized, its surgical application is different for patient compliance, work organization, costs, and diagnosis related group (DRG) reimbursements. Methods. We compared four surgical protocols presently used in our region: (A) traditional BCS with axillary lymph node dissection (ALND); (B) BCS with SLNB and concomitant ALND for positive sentinel nodes (SN); (C) BCS and SLNB under local anaesthesia with subsequent ALND under general anaesthesia according to the SN result; (D) SLNB under local anaesthesia with subsequent BCS under local anaesthesia for negative SN, or ALND under general anaesthesia for positive SN. For each protocol, patient compliance, use of consumables, resources and time spent by various dedicated professionals, were analyzed. Furthermore, a detailed breakdown of 1-/2-day hospitalization costs was calculated using specific DRGs. Results. We reported a mean costs variation that ranged from 1,634 to 2,221 Euros (protocols C and D). The number of procedures performed and the pathologists' results are the most significant variables affecting the rate of DRG reimbursements, that were the highest for protocol D and the lowest for protocol B. Conclusions. In our experience protocol C is the most suitable in terms of patient compliance, impact of surgical procedures, and work organization, and is granted by an appropriate DRG. We observed that a multidisciplinary approach enhances overall patient care and that a revaluation of DRG reimbursements is opportune.

Original languageEnglish
Pages (from-to)83-89
Number of pages7
JournalQuarterly Journal of Nuclear Medicine and Molecular Imaging
Volume56
Issue number1
Publication statusPublished - Feb 2012

Fingerprint

Sentinel Lymph Node Biopsy
Diagnosis-Related Groups
Lymph Node Excision
Breast Neoplasms
Local Anesthesia
Patient Compliance
Costs and Cost Analysis
General Anesthesia
Patient Care
Hospitalization
cyhalothrin

Keywords

  • Breast neoplasms
  • Diagnosis related group
  • Lymph node excision
  • Sentinel lymph node biopsy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Financial aspects of sentinel lymph node biopsy in early breast cancer. / Severi, S.; Gazzoni, E.; Pellegrini, A.; Sansovini, M.; Raulli, G.; Corbelli, C.; Altini, M.; Paganelli, G.

In: Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 56, No. 1, 02.2012, p. 83-89.

Research output: Contribution to journalArticle

Severi S, Gazzoni E, Pellegrini A, Sansovini M, Raulli G, Corbelli C et al. Financial aspects of sentinel lymph node biopsy in early breast cancer. Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2012 Feb;56(1):83-89.
Severi, S. ; Gazzoni, E. ; Pellegrini, A. ; Sansovini, M. ; Raulli, G. ; Corbelli, C. ; Altini, M. ; Paganelli, G. / Financial aspects of sentinel lymph node biopsy in early breast cancer. In: Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2012 ; Vol. 56, No. 1. pp. 83-89.
@article{0a1aa7df82804a0e80521f0ad860db3b,
title = "Financial aspects of sentinel lymph node biopsy in early breast cancer",
abstract = "Aim. At present, early breast cancer is treated with conservative surgery of the primary lesion (BCS) along with axillary staging by sentinel lymph node biopsy (SLNB). Although the scintigraphic method is standardized, its surgical application is different for patient compliance, work organization, costs, and diagnosis related group (DRG) reimbursements. Methods. We compared four surgical protocols presently used in our region: (A) traditional BCS with axillary lymph node dissection (ALND); (B) BCS with SLNB and concomitant ALND for positive sentinel nodes (SN); (C) BCS and SLNB under local anaesthesia with subsequent ALND under general anaesthesia according to the SN result; (D) SLNB under local anaesthesia with subsequent BCS under local anaesthesia for negative SN, or ALND under general anaesthesia for positive SN. For each protocol, patient compliance, use of consumables, resources and time spent by various dedicated professionals, were analyzed. Furthermore, a detailed breakdown of 1-/2-day hospitalization costs was calculated using specific DRGs. Results. We reported a mean costs variation that ranged from 1,634 to 2,221 Euros (protocols C and D). The number of procedures performed and the pathologists' results are the most significant variables affecting the rate of DRG reimbursements, that were the highest for protocol D and the lowest for protocol B. Conclusions. In our experience protocol C is the most suitable in terms of patient compliance, impact of surgical procedures, and work organization, and is granted by an appropriate DRG. We observed that a multidisciplinary approach enhances overall patient care and that a revaluation of DRG reimbursements is opportune.",
keywords = "Breast neoplasms, Diagnosis related group, Lymph node excision, Sentinel lymph node biopsy",
author = "S. Severi and E. Gazzoni and A. Pellegrini and M. Sansovini and G. Raulli and C. Corbelli and M. Altini and G. Paganelli",
year = "2012",
month = "2",
language = "English",
volume = "56",
pages = "83--89",
journal = "Quarterly Journal of Nuclear Medicine and Molecular Imaging",
issn = "1824-4785",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Financial aspects of sentinel lymph node biopsy in early breast cancer

AU - Severi, S.

AU - Gazzoni, E.

AU - Pellegrini, A.

AU - Sansovini, M.

AU - Raulli, G.

AU - Corbelli, C.

AU - Altini, M.

AU - Paganelli, G.

PY - 2012/2

Y1 - 2012/2

N2 - Aim. At present, early breast cancer is treated with conservative surgery of the primary lesion (BCS) along with axillary staging by sentinel lymph node biopsy (SLNB). Although the scintigraphic method is standardized, its surgical application is different for patient compliance, work organization, costs, and diagnosis related group (DRG) reimbursements. Methods. We compared four surgical protocols presently used in our region: (A) traditional BCS with axillary lymph node dissection (ALND); (B) BCS with SLNB and concomitant ALND for positive sentinel nodes (SN); (C) BCS and SLNB under local anaesthesia with subsequent ALND under general anaesthesia according to the SN result; (D) SLNB under local anaesthesia with subsequent BCS under local anaesthesia for negative SN, or ALND under general anaesthesia for positive SN. For each protocol, patient compliance, use of consumables, resources and time spent by various dedicated professionals, were analyzed. Furthermore, a detailed breakdown of 1-/2-day hospitalization costs was calculated using specific DRGs. Results. We reported a mean costs variation that ranged from 1,634 to 2,221 Euros (protocols C and D). The number of procedures performed and the pathologists' results are the most significant variables affecting the rate of DRG reimbursements, that were the highest for protocol D and the lowest for protocol B. Conclusions. In our experience protocol C is the most suitable in terms of patient compliance, impact of surgical procedures, and work organization, and is granted by an appropriate DRG. We observed that a multidisciplinary approach enhances overall patient care and that a revaluation of DRG reimbursements is opportune.

AB - Aim. At present, early breast cancer is treated with conservative surgery of the primary lesion (BCS) along with axillary staging by sentinel lymph node biopsy (SLNB). Although the scintigraphic method is standardized, its surgical application is different for patient compliance, work organization, costs, and diagnosis related group (DRG) reimbursements. Methods. We compared four surgical protocols presently used in our region: (A) traditional BCS with axillary lymph node dissection (ALND); (B) BCS with SLNB and concomitant ALND for positive sentinel nodes (SN); (C) BCS and SLNB under local anaesthesia with subsequent ALND under general anaesthesia according to the SN result; (D) SLNB under local anaesthesia with subsequent BCS under local anaesthesia for negative SN, or ALND under general anaesthesia for positive SN. For each protocol, patient compliance, use of consumables, resources and time spent by various dedicated professionals, were analyzed. Furthermore, a detailed breakdown of 1-/2-day hospitalization costs was calculated using specific DRGs. Results. We reported a mean costs variation that ranged from 1,634 to 2,221 Euros (protocols C and D). The number of procedures performed and the pathologists' results are the most significant variables affecting the rate of DRG reimbursements, that were the highest for protocol D and the lowest for protocol B. Conclusions. In our experience protocol C is the most suitable in terms of patient compliance, impact of surgical procedures, and work organization, and is granted by an appropriate DRG. We observed that a multidisciplinary approach enhances overall patient care and that a revaluation of DRG reimbursements is opportune.

KW - Breast neoplasms

KW - Diagnosis related group

KW - Lymph node excision

KW - Sentinel lymph node biopsy

UR - http://www.scopus.com/inward/record.url?scp=84861302934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861302934&partnerID=8YFLogxK

M3 - Article

C2 - 21068708

AN - SCOPUS:84861302934

VL - 56

SP - 83

EP - 89

JO - Quarterly Journal of Nuclear Medicine and Molecular Imaging

JF - Quarterly Journal of Nuclear Medicine and Molecular Imaging

SN - 1824-4785

IS - 1

ER -